The meeting will take place June 12–14, 2027, at Hurdalsjøen Hotel, Norway. The call for abstracts will open in autumn 2026.

Webpage: https://www.wolfsberg-oslo-radiation.com/

Founded in 1997, the Wolfsberg meetings are recognized as leading international conferences in applied radiation biology. They bring together basic scientists in molecular and cell biology, tumor biology, and radiation biology, alongside preclinical and clinical researchers in experimental radiation oncology.

The conference includes keynote and invited lectures, proffered papers, and focused poster sessions across four main themes: DNA repair, intra- and intercellular signaling, the tumor microenvironment, and novel therapies and biomarkers.

We look forward to welcoming you and to stimulating discussions in applied radiobiology.

Prof. Ludwig Dubois
Dept. Experimental and Translational Radiobiology, University of Manchester

Prof. Heidi Lyng
Dept. Radiation Biology, Oslo University Hospital

Prof. Martin Pruschy
Dept. Radiation Oncology, University Hospital Zurich

Dr. Randi Syljuåsen,
Dept. Radiation Biology, Oslo University Hospital

Shorter courses of radiation effective for treatment of slow-growing skin cancers

By News Medical Life Sciences

A recent Penn State College of Medicine physician's study review suggests that shorter courses of radiation are preferable to longer ones for older patients receiving treatment for slow-growing skin cancers.

Skin basal and squamous cell cancers are common among patients over 60 years old and are rarely fatal. These cancers-;which look like moles, freckles or skin tags-;can be removed surgically but in some cases radiation therapy is preferred. Doctors often recommend radiation when these cancers appear in areas such as near the eyes, ears, nose or lips, or in patients on blood thinners or with other health problems that rule out surgery.

Radiation therapy for these skin cancers is delivered in a series of treatments over anywhere from one to six weeks. Shorter-course therapy requires larger doses per treatment, which are expected to cause more damage to the skin that appears years later. Yet, no large study has actually compared the results of different-length courses of radiation therapy for these cancers. LEARN MORE

First International School of Radiation Research (ISRR-2017) Theme: Radiation Carcinogenesis-Mechanisms and Experimental Models.

This will be organized under the aegies of SRR during February 2nd-4th, 2017 at Annamalai University, Annamalai Nagar, Tamilanadau, India.

The school will cover lectures on the following topics by eminent scientists and experts from India and abroad:

• Basic of Cancer and Carcinogenisis
• DNA damage and genomic instability in the mechanism of carcinogenesis
• Radiation Biological concepts and radiaion carcinogenesis
• UV induces carcinogenesis
• Experimental models for carcinogenesis studies
• Carcinogenesis during cancer radiotherapy and accidental radiation exposure

Additionally, during the school, hands-on-training/ demonstration will be provided on techniques like DNA damage, apoptosis, oxidative damage, expression of oncogenes in tumor samples, histopathology of tumor samples.

Details about the School: HERE

Join us at the Proton Therapy Congress, at which leaders from a multitude of scientific disciplines will showcase unpublished data, new technological advances and translational case studies to highlight the strengths of proton therapy and address the challenges surrounding its optimisation and practical implementation. Stake your share in this exciting emerging market for proton therapy in the UK, as the first centres are being built for as early as 2017.

The conference will not only combine content from academics carrying out research and clinicians delivering the treatment, but also consider the practical aspects of proton therapy, from the health economics of high cost cancer treatments, to the importance of IT networks. Adrian Crellin will describe the NHS approach, and sit on a comprehensive panel to discuss the practical implementation of the therapy. For proton therapy to be fully utilised, it relies on high-quality data showing clinical outcomes, and Jem Rashbass discusses the practical aspects of collecting and analysing this data.

Here are 5 key reasons why you should attend:

1.    The proton therapy industry is growing rapidly. The first UK centres are currently under construction and many more are planned globally.

2.    This conference will provide an impartial platform for education and discussion.

3.    This is a unique opportunity to discuss ideas and identify strategies for development.

4.    Network with top academics and clinicians, private enterprises, government bodies, ground breaking solution providers and industry leaders.

5.    There will be a focus on unpublished data, new technological advances and translational case studies to highlight not only the strengths of proton therapy, but also the challenges surrounding its optimisation, and practical implementation.
Contact events@kisacoresearch.com for a copy of the agenda today or download it from www.protontherapycongress.com.  Save 15% off when you book online with code DL15.  

Search Keywords:
Proton Beam Therapy, Tumour, Particle Therapy, Proton Accelerator, Radiology, High Accuracy/Precision, Cancer, PBT, Radiation Treatment, Proton Therapy Center